Abstract: This invention relates to tacrolimus injection comprising tacrolimus as an active ingredient, macrogol 15 hydroxystearate as a surfactant and a non-aqueous solvent.
Type:
Application
Filed:
November 11, 2005
Publication date:
May 29, 2008
Applicant:
Chong Kun Dang Pharmaceutical Corporation
Inventors:
Sang Joon Lee, Hee Jong Shin, Seok Kyu Lee, Ji Hun Yun
Abstract: The present invention relates to a thiazolidinedione derivative, represented in formula (1) below, pharmaceutically acceptable salts thereof, and/or pharmaceutically acceptable solvates thereof. Further, the present invention provides a pharmaceutical composition comprising the compound represented in formula (1) below,
wherein:
X represents a carbon or nitrogen atom, Y represents a hydrogen atom, an alkyl group, an alkoxy group, a halogen, or an aryl group, Z represents an oxygen, nitrogen, or sulfur atom, and R1 and R2 each represent a hydrogen atom; or R1 and R2 together form a bond.
Type:
Grant
Filed:
July 3, 2003
Date of Patent:
September 7, 2004
Assignee:
Chong Kun Dang Pharmaceutical Corporation